Atorvastatin

New detailed data from the phase 3 GAUSS-3 ( Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects-3...


The aim of a study was to evaluate the effect of Atorvastatin on lipid lowering, cardiovascular events, and adverse events...


A study has analysed the treatment and control of dyslipidaemia in patients at high and very high cardiovascular risk being...


New detailed data from the phase 3 YUKAWA-2 study evaluating Evolocumab ( Repatha ), a novel investigational cholesterol-lowering medication, in...


Acute kidney injury ( AKI ) is common in patients undergoing cardiac surgery among whom it is associated with poor...


Recent trials have shown a reduction in the risk of major adverse cardiac events ( MACE ) with Simvastatin and...


Results from ETC-1002-009, a phase 2b study evaluating the efficacy and safety of ETC-1002 ( Bempedoic acid ) compared with...


Despite current standard-of-care, many patients at high cardiovascular disease ( CVD ) risk still have elevated low-density lipoprotein cholesterol (...


A study has determined all-cause mortality in patients with a first myocardial infarct who were treated with Simvastatin ( Zocor...


Secretory phospholipase A2 ( sPLA2 ) generates bioactive phospholipid products implicated in atherosclerosis. The sPLA2 inhibitor Varespladib has favorable effects...


A study looking at the data of thousands of patients who suffered myocardial infarctions has suggested treatment with high-potency statins...


Siltuximab ( Sylvant ) is an anti-interleukin-6 ( IL-6 ) chimeric monoclonal antibody that binds to human IL-6.1 IL-6 is...


Statins ( HMG-CoA reductase inhibitors ) are widely used medicines for patients with lipid disorders and in the primary and...


Edoxaban ( Lixiana ), an oral direct factor Xa inhibitor, is in development for thromboprophylaxis, including prevention of stroke and...


The purpose of the study was to compare the incidence of new-onset diabetes ( NOD ) with cardiovascular event reduction...


People who stop taking cholesterol drugs ( statins ) may be at an increased risk for developing Parkinson's disease, according...


Pfizer has informed Healthcare Professional of updated prescribing advice for Atorvastatin ( Lipitor ). The new advice relates to interactions...


Pfizer has informed Healthcare Professional of updated prescribing advice for Atorvastatin ( Lipitor ). The new advice relates to interactions...


A newly developed DNA vaccine appears safe and may produce beneficial changes in the brains and immune systems of individuals...


There are conflicting data regarding whether statins predominantly metabolized by CYP3A4 reduce the metabolism of Clopidogrel ( Plavix ) to...